Stan Stoyanov, MD, MBA
Stan is a physician-scientist with over 25 years of experience in global clinical development, regulatory strategy, and drug development. His work spans rare diseases, immunology, and biologics, with contributions to multiple clinical programs from early-phase trials to post-marketing. He has held leadership roles at Teva Pharmaceuticals, Intercept Pharmaceuticals, Boehringer Ingelheim, AstraZeneca, and Merck, playing a key role in bringing several therapies to market and leading regulatory submissions across the U.S., Europe, Japan, and Australia. With a strong background in cross-functional team leadership and collaboration, Stan works to align clinical development with corporate objectives. He holds an MD from Sofia Medical University and an MBA from St. John’s University.